The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-19

We compared the prognosis of inpatients with a known diagnosis of Alzheimer's or Parkinson's disease who have COVID-19 infection with other hospitalized patients with COVID-19. Our cohort study started in October 2020 and ended in May 2021 and included inpatients with COVID-19 infection wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Fathi, M., Taghizadeh, F., Mojtahedi, H., Zargar Balaye Jame, S., Markazi Moghaddam, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435376/
https://www.ncbi.nlm.nih.gov/pubmed/34556345
http://dx.doi.org/10.1016/j.neurol.2021.08.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435376/
https://www.ncbi.nlm.nih.gov/pubmed/34556345
http://dx.doi.org/10.1016/j.neurol.2021.08.002

Ejemplares similares